Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
DI Swerdlow, DA Rider, A Yavari et al.
KEYWORDS
lipoprotein(a)-mediated cardiovascular disease; treatment option; RNA interference therapeutics